Historic! Surgeons Transplant PIG LUNG Into Human

Surgeons performing an operation in a sterile environment.

Chinese surgeons have achieved a historic medical breakthrough that could revolutionize organ transplantation and save countless American lives trapped on waiting lists by successfully transplanting a genetically modified pig lung into a human recipient.

Story Highlights

First-ever pig-to-human lung transplant performed in China functions for nine days before rejection
Genetically modified pig lung successfully delivered oxygen and removed carbon dioxide in brain-dead recipient
Breakthrough could address critical organ shortage affecting over 100,000 Americans on waiting lists
China positions itself as global leader in xenotransplantation research and medical innovation

Historic Medical Milestone Achieved

Surgeons at the First Affiliated Hospital of Guangzhou Medical University successfully transplanted a genetically modified pig lung into a brain-dead human recipient in May 2024, with results published in Nature Medicine. The transplanted lung functioned for nine consecutive days, successfully delivering oxygen to the bloodstream and removing carbon dioxide. Dr. Jianxing He and his medical team used multiple genetic modifications to reduce immune rejection, marking the first time a pig lung has been successfully transplanted into a human being.

Nine-Day Success Despite Immune Challenges

The genetically engineered pig lung demonstrated remarkable functionality during the initial transplant period, performing essential respiratory functions that could save lives. Beginning on day three, researchers observed early signs of inflammation and immune response as the recipient’s body began attacking the foreign organ. Despite these challenges, the lung continued operating until day nine, when immune rejection ultimately caused organ failure, providing crucial data for future xenotransplantation research.

Global Organ Crisis Demands Innovation

This breakthrough addresses a devastating healthcare crisis where only ten percent of global organ needs are currently met, leaving thousands of Americans to die waiting for transplants. Previous xenotransplantation successes include pig kidney transplants in 2021 and pig heart transplants in 2022, demonstrating growing momentum in cross-species organ research. The lung transplant represents particularly significant progress since respiratory organs face unique challenges in maintaining function outside their original biological system.

China’s Scientific Leadership Emerges

China’s achievement in xenotransplantation research signals the nation’s growing dominance in cutting-edge medical innovation, potentially shifting global leadership away from American institutions. The successful procedure required sophisticated genetic engineering, advanced surgical techniques, and extensive research infrastructure that demonstrates China’s substantial investment in biotechnology. Richard Pierson III from Massachusetts General Hospital called the work “exciting” and acknowledged it as a significant step forward for the entire field of organ transplantation.

Future Clinical Applications

Researchers emphasize that while this experiment proves pig lungs can function in humans, significant challenges remain before clinical applications become reality. Further research must address immune rejection mechanisms and develop more effective genetic modifications to extend organ viability beyond nine days. The study provides essential data for regulatory agencies and medical ethics committees who will ultimately determine when xenotransplantation procedures can safely transition from experimental protocols to life-saving treatments for desperate patients.